× Alert! To view the full data details, please Login or Register. Synopsis: VC SBIR-STTR Data Acquired Firms 2,807 (8.66%) Acquiring Entities 1,771 Transactions 2,881 M&A Deals Value $538.4B VC Funded Firms 1,295 Total VC Investment $48.6B Distribution of M&A transactions SBIR M&A Deals Value: non-VC & VC Funded Firms (last 10 years) SBIR M&A Num Deals: non-VC & VC Funded Firms (last 10 years) SBIR M&A Key Takeaways SBIR M&A by Price Paid: non-VC & VC Funded Firms Featured SBIR Firm Catalyst Biosciences Inc In August 2015, Catalyst Biosciences did a reverse merger with publicly traded Targacept - SBIR involved. The created entity trades under the symbol NASDAC:CBIO). Only marginally involved in SBIR in its own right, Catalyst Biosciences is a drug disco... see more www.catbio.com | (650) 871-0761 SBIR M&A & Partnering News Date Title Nov 13 2023 Selecta Biosciences Announces Merger with Cartesian Therapeutics Aug 22 2023 Grander Closes Acquisition of PolarityTE, Inc. Assets Aug 08 2023 Arcfield Acquires Strategic Technology Consulting Aug 08 2023 Alchemist Completes Acquisition of Aqueous Resources LLC, a Leader in Industrial Brine Pre-Treatment Solutions and Direct Lithium Extraction Jul 17 2023 Novartis Acquires DTx Pharma in Potential $1B Deal Explanation ×